Nova Scotia is reporting 17 new cases of COVID 19 and two deaths.
Two men in their 60s have died in the Halifax region.
There are 12 new cases in Central Zone. Eight of the cases are close contacts of previously reported cases, two are related to travel and two are under investigation.
Three cases are in Eastern Zone and are close contacts of previously reported cases. One case is in Northern Zone and is related to travel while one case is in Western Zone and is currently under investigation.
Meantime, the province has confirmed its first case of a rare blood clotting condition related to the AstraZeneca vaccine. The person is a man who received his first dose of the vaccine in early May.
He developed symptoms about two weeks after vaccination and is recovering.
“I am relieved to hear that the man who experienced a rare blood clotting event following his vaccination has received treatment and is now recovering,” said Premier Iain Rankin. “I want to remind Nova Scotians that events like this are rare. Nova Scotians who received the AstraZeneca vaccine should feel confident in their decision and can choose between the AstraZeneca, Pfizer or Moderna vaccine for their second dose.”
Meantime, Dr. Robert Strang says anyone with serious side effects to a vaccine should seek medical attention right away.
“All COVID-19 vaccines approved for use in Canada protect against severe illness or death from the virus, but we know there is a risk of developing a rare blood clotting condition for some people with the AstraZeneca vaccine,” said Dr. Robert Strang, Nova Scotia’s chief medical officer of health. “We have a process in place to monitor and report adverse events related to vaccinations in the province. Anyone who experiences an adverse event as a result of vaccination should report it to their health-care provider or seek immediate medical attention if it is an emergency.”
Nova Scotia has 311 active cases of the virus.
